Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02607865

Public ClinicalTrials.gov record NCT02607865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to investigate efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02607865
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,864 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 15, 2016 (Actual)
Primary completion
Feb 14, 2017 (Actual)
Completion
Mar 28, 2018 (Actual)
Last update posted
Jul 20, 2022

2016 – 2018

United States locations

U.S. sites
93
U.S. states
36
U.S. cities
84
Facility City State ZIP Site status
Novo Nordisk Investigational Site Anniston Alabama 36207 —
Novo Nordisk Investigational Site Birmingham Alabama 35211 —
Novo Nordisk Investigational Site Tuscumbia Alabama 35674 —
Novo Nordisk Investigational Site Glendale Arizona 85308 —
Novo Nordisk Investigational Site Little Rock Arkansas 72212 —
Novo Nordisk Investigational Site Carmichael California 95608 —
Novo Nordisk Investigational Site Coronado California 92118 —
Novo Nordisk Investigational Site Encino California 91436 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Los Alamitos California 90720 —
Novo Nordisk Investigational Site Palm Springs California 92262 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Denver Colorado 80220 —
Novo Nordisk Investigational Site Kissimmee Florida 34741 —
Novo Nordisk Investigational Site New Port Richey Florida 34652 —
Novo Nordisk Investigational Site Palm Harbor Florida 34684 —
Novo Nordisk Investigational Site Plantation Florida 33324 —
Novo Nordisk Investigational Site Port Charlotte Florida 33952 —
Novo Nordisk Investigational Site Spring Hill Florida 34609 —
Novo Nordisk Investigational Site Tampa Florida 33607 —
Novo Nordisk Investigational Site Marietta Georgia 30060 —
Novo Nordisk Investigational Site Perry Georgia 31069 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Meridian Idaho 83646 —
Novo Nordisk Investigational Site Gurnee Illinois 60031 —
Novo Nordisk Investigational Site Peoria Illinois 61602 —
Novo Nordisk Investigational Site Peoria Illinois 61603 —
Novo Nordisk Investigational Site Avon Indiana 46123 —
Novo Nordisk Investigational Site Park City Kansas 67219 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Paducah Kentucky 42001 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site Metairie Louisiana 70002 —
Novo Nordisk Investigational Site Natchitoches Louisiana 71457-5881 —
Novo Nordisk Investigational Site Shreveport Louisiana 71105 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Waltham Massachusetts 02453 —
Novo Nordisk Investigational Site Flint Michigan 48532 —
Novo Nordisk Investigational Site Sterling Heights Michigan 48310-3503 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site Butte Montana 59701-1652 —
Novo Nordisk Investigational Site Teaneck New Jersey 07666 —
Novo Nordisk Investigational Site Trenton New Jersey 08611 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87102 —
Novo Nordisk Investigational Site New Windsor New York 12553 —
Novo Nordisk Investigational Site Rochester New York 14607 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site High Point North Carolina 27265 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Whiteville North Carolina 28472 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Fargo North Dakota 58104 —
Novo Nordisk Investigational Site Cincinnati Ohio 45219 —
Novo Nordisk Investigational Site Cincinnati Ohio 45236 —
Novo Nordisk Investigational Site Columbus Ohio 43203 —
Novo Nordisk Investigational Site Columbus Ohio 43213 —
Novo Nordisk Investigational Site Franklin Ohio 45005 —
Novo Nordisk Investigational Site Maumee Ohio 43537 —
Novo Nordisk Investigational Site Toledo Ohio 43623 —
Novo Nordisk Investigational Site Norman Oklahoma 73069 —
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737 —
Novo Nordisk Investigational Site Jersey Shore Pennsylvania 17740 —
Novo Nordisk Investigational Site McMurray Pennsylvania 15317 —
Novo Nordisk Investigational Site Gaffney South Carolina 29341 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Pelzer South Carolina 29669 —
Novo Nordisk Investigational Site Summerville South Carolina 29485 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Humboldt Tennessee 38343 —
Novo Nordisk Investigational Site Jackson Tennessee 38305 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Dallas Texas 75226 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Houston Texas 77081 —
Novo Nordisk Investigational Site Longview Texas 75605 —
Novo Nordisk Investigational Site Plano Texas 75093 —
Novo Nordisk Investigational Site San Antonio Texas 78209 —
Novo Nordisk Investigational Site San Antonio Texas 78224 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Waco Texas 76710 —
Novo Nordisk Investigational Site Murray Utah 84123 —
Novo Nordisk Investigational Site South Burlington Vermont 05403 —
Novo Nordisk Investigational Site Richmond Virginia 23219 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Spokane Washington 99218 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02607865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02607865 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →